Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways

Glioblastoma (GBM) is the most commonly diagnosed brain tumor that exhibit high mortality rate and chemotherapy resistance is a major clinical problem. Recent studies suggest that estrogen receptor beta (ERβ), may function as a tumor suppressor in GBM. However, the mechanism(s) by which ERβ contribu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Mei, Sareddy, Gangadhara R., Li, Mengxing, Liu, Jinyou, Luo, Yiliao, Venkata, Prabhakar Pitta, Viswanadhapalli, Suryavathi, Tekmal, Rajeshwar R., Brenner, Andrew, Vadlamudi, Ratna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467924/
https://www.ncbi.nlm.nih.gov/pubmed/30992459
http://dx.doi.org/10.1038/s41598-019-42313-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467924/
https://www.ncbi.nlm.nih.gov/pubmed/30992459
http://dx.doi.org/10.1038/s41598-019-42313-8

Ejemplares similares